HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Necrosis of the optic nerve and chiasm with safe radiation doses: Report of two rare cases.

AbstractINTRODUCTION:
Radiation-induced optic neuropathy (RION) is still a devastating complication of brain and skull base radiation that has no effective treatment up until today, thus uttermost caution must be taken in treating patients that brain radiotherapy is needed. We present two cases of RION that happened in seemingly safe radiation doses.
CASE DESCRIPTION:
A 48-year-old female with a history of pleomorphic pituitary adenoma developed bilateral and painless loss of vision 10 months after radiation to the brain; the total radiation dose was 45 Gy in 25 fractions and no other risk factors of RION were found. Magnetic resonance imaging of the brain depicted bilateral prechiasmatic optic nerve enhancement with involvement of the optic chiasm. Treatment with high doses of corticosteroids was unsuccessful. A 62-year-old female with a history of lung adenocarcinoma and brain metastases presented with a 1-month history of decreased vision in both eyes. He had undergone whole-brain radiotherapy with a total dose of 30 Gy over 10 fractions and concurrent chemotherapy with cisplatin and pemetrexed. Brain magnetic resonance imaging (MRI) with contrast showed bilateral intracranial optic nerve enhancement.
CONCLUSIONS:
This is the second case report of RION in a patient with a history of brain radiotherapy and concurrent chemotherapy with pemetrexed. History of chiasmal compression, concurrent use of chemotherapeutic agents, and high fraction size (despite the safety of total radiation dose) were possible contributing risk factors to develop RION in our cases. Hence, adjusting the radiation dose according to the presence of these risk factors is recommended.
AuthorsKaveh Abri Aghdam, Mostafa Soltan Sanjari, Mohsen Khosravi Farsani, Mehdi Moghadasi, Ali Aghajani
JournalEuropean journal of ophthalmology (Eur J Ophthalmol) Vol. 32 Issue 3 Pg. NP28-NP32 (May 2022) ISSN: 1724-6016 [Electronic] United States
PMID33499669 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Pemetrexed
Topics
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Necrosis (complications)
  • Optic Chiasm (pathology)
  • Optic Nerve (pathology)
  • Optic Nerve Diseases (diagnosis, drug therapy, etiology)
  • Pemetrexed (therapeutic use)
  • Radiation Dosage
  • Radiation Injuries (diagnosis, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: